Abstract
We tested the activity of BAL30072, a novel siderophore monobactam, against multiresistant clinical isolates of Pseudomonas aeruginosa, Burkholderia cepacia group and Acinetobacter spp. and against laboratory P. aeruginosa strains with defined resistance mechanisms.
Original language | English |
---|---|
Pages (from-to) | 266-270 |
Number of pages | 5 |
Journal | Journal of Antimicrobial Chemotherapy |
Volume | 65 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2010 |
Keywords
- Acinetobacter
- Anti-Bacterial Agents
- Bacterial Proteins
- Burkholderia cepacia complex
- Drug Resistance, Multiple, Bacterial
- Gram-Negative Bacterial Infections
- Great Britain
- Humans
- Microbial Sensitivity Tests
- Monobactams
- Pseudomonas aeruginosa
- beta-Lactamases